537 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Ovarian Diseases" (537 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
2 Recruiting Mediterranean Diet Versus Hypocaloric Diet in PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet, restricted calorie;   Other: hypocaloric diet, restricted calorie
3 Recruiting Mediterranean Diet as Treatment for Normal Weight Women With PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet;   Other: normocaloric diet
4 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
5 Not yet recruiting PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Neoplasms
Interventions: Drug: Olaparib;   Drug: Tremelimumab
6 Recruiting The SOCQER-2 Study Surgery in Ovarian Cancer - Quality of Life Evaluation Research
Condition: Ovarian Neoplasms
Intervention: Other: Observational cohort
7 Recruiting Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Malignant Ovarian Endometrioid Tumor;   Malignant Ovarian Serous Tumor;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma
Interventions: Drug: Topotecan Hydrochloride;   Drug: Acetylcysteine
8 Not yet recruiting Cardiovascular Risks and Urinary Albumin Excretion(UAE) in Polycystic Ovarian Syndrome (PCO)
Condition: Urinary Albumin Excretion
9 Not yet recruiting Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Conditions: Estrogen Receptor Negative;   Head and Neck Squamous Cell Carcinoma;   HER2/Neu Negative;   Hormone-Resistant Prostate Cancer;   Metastatic Pancreatic Adenocarcinoma;   Progesterone Receptor Negative;   Solid Neoplasm;   Stage III Mesothelioma;   Stage IIIA Gastric Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Small Cell Lung Carcinoma;   Stage IIIB Gastric Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Small Cell Lung Carcinoma;   Stage IIIC Gastric Cancer;   Stage IIIC Ovarian Cancer;   Stage IV Mesothelioma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Ovarian Cancer;   Stage IV Small Cell Lung Carcinoma;   Triple-Negative Breast Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Talazoparib
10 Not yet recruiting Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer
Conditions: Ovarian Cancer;   Primary Peritoneal Cancer
Interventions: Procedure: Cytoreductive surgery;   Drug: IPEC with Cisplatin (75mg/m²);   Drug: IPEC with Cisplatin (120mg/m²);   Drug: Hypertherm IntraPEritoneal Chemotherapy with Cisplatin (75mg/m²);   Drug: HIPEC with Cisplatin (120mg/m²)
11 Not yet recruiting Adjuvant Chemotherapy of Three-step Regimen in Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Etoposide, Cyclophosphamide, Carboplatin
12 Recruiting Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer
Conditions: Breast Cancer;   Transcriptomes;   Molecular Diagnostic;   Ovarian Cancer
Interventions: Other: collection of a blood sample and breast tissue;   Other: use of a previous blood collection for patients
13 Recruiting Cabazitaxel vs. Tocotrienol in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.
Condition: Ovarian Cancer
Interventions: Drug: Cabazitaxel;   Drug: Tocotrienol
14 Not yet recruiting HuMax®-TF-ADC Safety Study in Patients With Solid Tumors
Conditions: Ovary Cancer;   Cervix Cancer;   Endometrium Cancer;   Bladder Cancer;   Prostate Cancer (CRPC);   Esophagus Cancer;   Lung Cancer (NSCLC)
Intervention: Drug: HuMax-TF-ADC
15 Not yet recruiting Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS )
Conditions: Anovulation;   Polycystic Ovary Syndrome
Interventions: Drug: Letrozole;   Drug: Clomiphene citrate;   Drug: hcg hormone
16 Not yet recruiting Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Paclitaxel;   Radiation: LDWART (Low Dose Whole Abdominal Radiation Therapy)
17 Recruiting Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133
Conditions: Liver Cancer;   Pancreatic Cancer;   Brain Tumor;   Breast Cancer;   Ovarian Tumor;   Colorectal Cancer;   Acute Myeloid and Lymphoid Leukemias
Intervention: Biological: anti-CD133-CAR vector-transduced T cells
18 Not yet recruiting Sentinel Node Detection in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Sentinel Node
Intervention: Procedure: Injection of radioactive tracer combined with Patent Blue
19 Not yet recruiting Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer
Conditions: Malignant Ascites;   Ovarian Cancer
Interventions: Biological: BAX69 Single-Route Arm;   Biological: BAX69 Double-Route Arm
20 Recruiting Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: SC-003

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years